National Register of Moderate and Severe Adult Atopic Dermatitis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSocieta Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

About this trial

Collect clinical history and treatment data of AD in adulthood;

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years

Signature of informed consent

EASI 16

location in at least one of the following "critical" locations: face, hands, genitals

Disqualifiers

Patient unable to provide informed consent prior to any collection procedures data on the study;

unable to complete the procedures required for the study;

a patient already participating in another follow-up register of the same disease.

Trial population

The nature of the study is descriptive. Each centre undertakes to recruit all adult patients diagnosed with moderate-severe atopic dermatitis observed at the center.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Epidemiological data

Reassessment of the epidemiology of AD

Time frame
from baseline through study completion, an average of 3 year
2

Identification of factors for specific treatment

Assessment of treatment profiles and identification of factors that determine the decision about the specific treatment of moderate and severe AD

Time frame
from baseline through study completion, an average of 3 year
3

clinical and therapeutic data

Assessment of any comorbidities;

Time frame
from baseline through study completion, an average of 3 year
4

characterization of diagnostic criteria

Outlining possible diagnostic criteria specific to AD in adults;

Time frame
from baseline through study completion, an average of 3 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.